Skip to search formSkip to main contentSkip to account menu

leptomycin B

Known as: 2,10,12,16,18-Nonadecapentaenoic acid, 19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-8-oxo-, elactocin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Analysis of the nuclear life of human Pat1b, a member of the Pat1 family of RNA-binding proteins that at steady state reside in… 
2011
2011
PurposeLeptomycin B (LMB) and/or its derivatives are considered a novel class of cancer therapeutics through blocking chromosome… 
Highly Cited
2006
Highly Cited
2006
The BCR-ABL oncoprotein of chronic myelogenous leukemia (CML) localizes to the cell cytoplasm, where it activates proliferative… 
Highly Cited
2003
Highly Cited
2003
Posttranslational modification by small ubiquitin-like modifier (SUMO) conjugation regulates the subnuclear localization of… 
Highly Cited
2000
Highly Cited
2000
ABSTRACT Rel and IκB protein families form a complex cellular regulatory network. A major regulatory function of IκB proteins is… 
Highly Cited
2000
Highly Cited
2000
Wild-type p53 is stabilized and accumulates in the nucleus of DNA damaged cells. The effect of stabilizing p53 is to inhibit cell… 
Highly Cited
1992
Highly Cited
1992
Screening for leptomycin B (LMB)‐resistant transformants in a gene library constructed in Schizosaccharomyces pombe with the…